A pharmaceutical sponsor sought to strengthen its engagement with the chronic kidney disease (CKD) community and establish a more strategic, patient-centered approach to advocacy. The organization recognized the need for a deeper understanding of the advocacy landscape, unmet patient needs, and opportunities to engage underserved populations while ensuring that patient perspectives were incorporated into corporate planning and decision-making.
The sponsor wanted a more structured approach to patient engagement that would help build stronger relationships within the kidney community and better align internal priorities with patient needs.
PAS partnered with the sponsor to design and implement a comprehensive patient advocacy and engagement strategy focused on chronic kidney disease. The initiative included advocacy landscape assessments, stakeholder mapping, social and digital listening, patient insight gathering, and evaluation of opportunities to better engage underrepresented patient populations.
Using these findings, PAS developed a long-term engagement roadmap and strategic recommendations designed to strengthen advocacy partnerships, elevate patient perspectives, and support informed decision-making across the organization. The strategy provided a structured framework for integrating patient insights into cross-functional planning and engagement activities.
The advocacy strategy generated actionable patient insights that informed organizational priorities and strengthened engagement efforts across the company. The sponsor enhanced its visibility and credibility within the kidney community through expanded advocacy partnerships and more patient-centered initiatives.
Targeted outreach efforts also amplified diverse patient perspectives and increased engagement with underserved populations, helping the organization build stronger relationships throughout the CKD community while incorporating the patient voice more consistently into corporate decision-making.
Category:
